期刊
CURRENT ALLERGY AND ASTHMA REPORTS
卷 17, 期 4, 页码 -出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11882-017-0688-z
关键词
Severe asthma; Childhood asthma; Biomarkers; Biologic therapy; Pharmacologic therapy
资金
- AstraZeneca
- Boehringer Ingelheim
- Circassia
- Genentech Novartis
- Teva
Purpose of Review The aim of this study is to characterize, diagnose, evaluate, and treat severe childhood asthma. Recent Findings Understanding the occurrence of the physiologic and clinical presentations of childhood severe asthma, the treatment and response may be predicted by biomarkers, but the patient's response is highly variable. Summary The onset of severe asthma occurs early and is primarily predicted by severity of viral infection and coexistence of the atopic state.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据